This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.
We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.
Terms of use
Privacy Notice
Settings
This website uses cookies and similar technologies to provide the best functionality and display content according to your interests on our site and social networks.
We respect your privacy and process information only for marketing and functional purposes if you give us your consent by clicking ‘I accept.’
You can change your cookie settings at any time by clicking on the privacy settings.
Terms of use
Privacy Notice
System cookies (required)
This cookie is used for system purposes only and does not track user actions. It is required for normal functioning of this web site.
Google Analytics
This is a web analytics service.
Processing company
Google Ireland Limited
Google Building Gordon House, 4 Barrow St, Dublin, D04 E5W5, Ireland
Data Purposes
Marketing
Advertisement
Web Analytics
Technologies Used
Cookies
Pixel Tags
Data Attributes
IP address (anonymised)
Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
IP address
Date and time of visit
Usage data
Click path
App updates
Browser information
Device information
JavaScript support
Pages visited
Referrer URL
Downloads
Flash version
Location information
Purchase activity
Widget interactions
Legal Basis
In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 (1) (a) GDPR
Location of Processing
Republic of Serbia
Retention Period
The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
Alphabet Inc.
Facebook Pixel
This is a Tracking technology offered by Facebook and used by other Facebook services such as Facebook Custom Audiences.
Processing company
Facebook Ireland Limited
4 Grand Canal Square, Grand Canal Harbour, Dublin, D02, Ireland
Data Purposes
advertising
Marketing
Retargeting
Analyse
Tracking
Technologies Used
Cookies
Data Attributes
Pixel specific data
Http-Header
Optional Parameters
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
Facebook user ID
Browser information
Usage data
Geräteinformationen
Non-sensitive custom data
Referrer URL
Pixel ID
Location information
Pixel specific data
User behaviour
Ads viewed
Interactions with advertisement, services, and products
Marketing information
Content viewed
IP address
Legal Basis
In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 para. 1 s. 1 lit. a GDPR
Location of Processing
Republic of Serbia
Retention Period
The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
Facebook Inc.
Zoom Analytics
This is a web analytics service.
Processing company
Zoom Analytics Ltd.
Petah Tikva, Israel
Data Purposes
Marketing
Advertisement
Web Analytics
Technologies Used
Cookies
Pixel Tags
Data Attributes
IP address (anonymised)
Browser information (browser type, referring/exit pages, the files viewed on our site, operating system, date/time stamp, and/or clickstream data)
Usage Data (views, clicks)
Data Collected
This list represents all (personal) data that is collected by or through the use of this service.
IP address
Date and time of visit
Usage data
Click path
App updates
Browser information
Device information
JavaScript support
Pages visited
Referrer URL
Downloads
Flash version
Location information
Purchase activity
Widget interactions
Legal Basis
In the following the legal basis for the processing of personal data required by Art. 6 I 1 GDPR is listed.
Art. 6 (1) (a) GDPR
Location of Processing
Republic of Serbia
Retention Period
The data will be deleted as soon as they are no longer needed for the processing purposes.
Data Recipients
Alphabet Inc.
ENG
SRB
DEU
Home
About us
Business
Products
Responsibility
Career
Media
Blog
Contact
ENG
SRB
DEU
Home
About us
▾
Company profile
Mission and vision
Management
Representative offices
Production
Our history
Business
▾
R&D
Quality
Stakeholders
Code of Conduct
General conditions of business operations
Products
▾
Prescription drugs
Over-the-Counter Drugs
Medical devices
Dietary supplements
Consumer goods
Report adverse drug reactions
Responsibility
▾
Health and safety
Compliance
Employees
Social responsibility
Sustainable development
Career
▾
Corporate culture
Education of employees
Your career
Media
Blog
Contact
Home
›
Media
›
News
›
Keeping Trust Through Health Preservation
Keeping Trust Through Health Preservation
21. December 2020.
In the year marked by the coronavirus pandemic, Hemofarm managed in the ever more demanding environment to produce and deliver medicines
on time, in the required quantity and in the expected quality
to the markets of Serbia and around the world, which the company considers its greatest business success in recent months. Confirmation for Hemofarm's work also came from the parent company Stada, which awarded the Serbian company within the Group for the successful functioning of the supply chain in 2020.
‘Hemofarm has confirmed its leadership position in this jubilee year, when it celebrates its 60th birthday, but above all, it has shown in action what the fight for human health means. Even in times of the greatest crises, we are expected to work smoothly and ensure a regular supply of medicines to the market. That is why, throughout the year, our goal was to provide safe working conditions for employees and to produce enough medicines for everyone - both for our citizens in Serbia and for consumers in the European Union, Russia, etc. We worked hard and I sincerely believe that
our employees, together with health workers and pharmacists, were on the first line of health defense
. That is why I am very grateful to all the people in Hemofam, in the production sites, in the field, as well as those who showed from their homes what we can achieve together, ’said Hemofarm CEO Dr Ronald Seeliger.
If we compare the business results in this atypical year with those achieved in 2019, Hemofarm increased the volume of production with a maintained level of 280 million packages. Namely, the volume of produced units increased by six percent, so that
6.5 billion tablets and other forms
were produced in Hemofarm's plants this year.
Despite the difficulties that Covid-19 brought to the business environment, Hemofarm also managed to place
17 new products
on the market, such as a medicine for the treatment of moderate to severe acute and chronic pain in adults (tapentadol molecule), and a state-of-the-art medicine for osteoporosis patients, a biosimilar teriparatide. Midol Protect 75, Probiotic Daily, Magnetrans Duo are just some of the new products in the company's portfolio.
During the state of emergency, Hemofarm paid
a 10 percent salary incentive
to employees who worked at production sites on a daily basis, and given the consequences that the pandemic leaves not only on people's physical but also mental health, the company implemented a
psychological support program for employees
together with Hemofarm Foundation.
This program
included individual interviews with a psychologist, forums and workshops with psychologists, as well as numerous professional texts available on the internal portal.
It is known that Hemofarm regularly helps health and other institutions, and that was especially important during the current pandemic crisis. Stada and Hemofarm
donated 150 medical monitors worth about EUR 400,000
to Serbia, Bosnia and Herzegovina and Montenegro, the countries where they have production facilities. At the same time, Hemofarm Foundation supported Šabac and Vršac, cities where the company has production in Serbia, with five million dinars in the fight against coronavirus. In addition, protective equipment worth EUR 20,000 was donated to health workers in 18 primary healthcare centers in B&H.